Molecular Docking Analysis of Caspase-3 Activators as Potential Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Drug Discovery

Background:

• Caspase-3 is a key enzyme in apoptosis, making it a target for cancer therapy.
• Targeting apoptosis regulators is a promising strategy for anticancer drug discovery.
• 1,2,4-Oxadiazoles derivatives were investigated for their interaction with caspase-3.

Purpose of the Study:

• To investigate the binding potential of 1,2,4-Oxadiazoles derivatives with caspase-3.
• To understand the molecular interactions for designing novel anticancer agents.

Main Methods:

• Molecular docking studies using Autodock 4.2 and GOLD 5.2.
• Analysis of spatial arrangement and binding requirements for caspase-3 agonistic affinity.

Main Results:

• Docking studies elucidated the spatial disposition of ligands within the caspase-3 active site.
• Hydrogen bond interactions were observed between the top-ranked ligand and asparagine 273 (ASN 273).

Conclusions:

• The study identified key interactions between 1,2,4-Oxadiazoles and caspase-3.
• Asparagine 273 is crucial for ligand binding, offering insights for developing new cancer therapeutics.